Skip to main content
NCBI home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1994 Mar;38(3):558–562. doi: 10.1128/aac.38.3.558

Randomized comparison of aztreonam and chloramphenicol in treatment of typhoid fever.

E Gotuzzo 1, J Echevarría 1, C Carrillo 1, J Sánchez 1, P Grados 1, C Maguiña 1, H L DuPont 1
PMCID: PMC284497  PMID: 8203854

Abstract

Patients with clinical typhoid fever plus a blood, bone marrow, or bile positive for Salmonella typhi or Salmonella paratyphi were included in an open clinical trial to compare the efficacy of aztreonam (6 g/day [2 g intravenously every 8 h]) given for 10 days with that of chloramphenicol (50 mg/kg of body weight per day [intravenously or orally]) administered for 14 days. A total of 44 patients, 22 in each group, were included in the study, and both groups were comparable in terms of baseline parameters. All patients randomized to receive chloramphenicol completed the 14 days of treatment, while two patients randomized to receive aztreonam developed an intestinal hemorrhage, and a third patient elected to withdraw from the trial. Defervescence occurred more quickly in the subjects receiving chloramphenicol than in those receiving aztreonam (P < 0.05). All patients in the chloramphenicol group were clinically cured during therapy, while four patients (21%) in the group receiving aztreonam were declared clinical treatment failures. None of the 19 patients receiving aztreonam, compared with 7 of 22 (32%) patients receiving chloramphenicol, had a positive blood culture after 24 h of therapy (P < 0.05). Adverse experiences were unusual and mild. In the study, aztreonam was less effective than chloramphenicol with regard to clinical effectiveness and time of defervescence but was more effective in the elimination of the infecting Salmonella organisms from the bloodstream.

Full text

PDF
558

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Anderson E. S., Smith H. R. Chloramphenicol resistance in the typhoid bacillus. Br Med J. 1972 Aug 5;3(5822):329–331. doi: 10.1136/bmj.3.5822.329. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Cherubin C. E., Eng R. H., Smith S. M., Goldstein E. J. Cephalosporin therapy for salmonellosis. Questions of efficacy and cross resistance with ampicillin. Arch Intern Med. 1986 Nov;146(11):2149–2152. doi: 10.1001/archinte.146.11.2149. [DOI] [PubMed] [Google Scholar]
  3. DuPont H. L., Ericsson C. D., Mathewson J. J., de la Cabada F. J., Conrad D. A. Oral aztreonam, a poorly absorbed yet effective therapy for bacterial diarrhea in US travelers to Mexico. JAMA. 1992 Apr 8;267(14):1932–1935. [PubMed] [Google Scholar]
  4. Edelman R., Levine M. M. Summary of an international workshop on typhoid fever. Rev Infect Dis. 1986 May-Jun;8(3):329–349. doi: 10.1093/clinids/8.3.329. [DOI] [PubMed] [Google Scholar]
  5. Eykyn S. J., Williams H. Treatment of multiresistant Salmonella typhi with oral ciprofloxacin. Lancet. 1987 Dec 12;2(8572):1407–1408. doi: 10.1016/s0140-6736(87)91308-0. [DOI] [PubMed] [Google Scholar]
  6. Farid Z., Girgis N. I., Kamal M., Bishay E., Kilpatrick M. E. Successful aztreonam treatment of acute typhoid fever after chloramphenicol failure. Scand J Infect Dis. 1990;22(4):505–506. doi: 10.3109/00365549009027085. [DOI] [PubMed] [Google Scholar]
  7. Goldstein F. W., Chumpitaz J. C., Guevara J. M., Papadopoulou B., Acar J. F., Vieu J. F. Plasmid-mediated resistance to multiple antibiotics in Salmonella typhi. J Infect Dis. 1986 Feb;153(2):261–266. doi: 10.1093/infdis/153.2.261. [DOI] [PubMed] [Google Scholar]
  8. Herzog C., Geddes A. M. Chloramphenicol in the treatment of enteric fever. Trans R Soc Trop Med Hyg. 1982;76(6):848–849. doi: 10.1016/0035-9203(82)90123-7. [DOI] [PubMed] [Google Scholar]
  9. Islam A., Butler T., Nath S. K., Alam N. H., Stoeckel K., Houser H. B., Smith A. L. Randomized treatment of patients with typhoid fever by using ceftriaxone or chloramphenicol. J Infect Dis. 1988 Oct;158(4):742–747. doi: 10.1093/infdis/158.4.742. [DOI] [PubMed] [Google Scholar]
  10. Lorian V., Gardner D. A. Bacterial resistance to antibiotics in American hospitals. Chemioterapia. 1985 Feb;4(1):14–18. [PubMed] [Google Scholar]
  11. Robertson R. P., Wahab M. F., Raasch F. O. Evaluation of chloramphenicol and ampicillin in salmonella enteric fever. N Engl J Med. 1968 Jan 25;278(4):171–176. doi: 10.1056/NEJM196801252780401. [DOI] [PubMed] [Google Scholar]
  12. Tanaka-Kido J., Ortega L., Santos J. I. Comparative efficacies of aztreonam and chloramphenicol in children with typhoid fever. Pediatr Infect Dis J. 1990 Jan;9(1):44–48. doi: 10.1097/00006454-199001000-00010. [DOI] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES